Pfizer Deal Will Dramatically Reshape Mylan’s Model

31 Jul 2019

Following the announcement of a merger between Mylan and Pfizer’s Upjohn, the top executive team that will take charge of the combination has set out its vision for the company.

Potter — Merging with Upjohn will reshape Mylan’s business model • Source: Shutterstock

Merging with Pfizer’s Upjohn off-patent unit will dramatically remould Mylan’s business model, according to the leadership team of the combined company that is expected to be operational from mid-2020.

The deal – announced on 29 July – will see the firms combined in an all-stock transaction under a ‘reverse...